The Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
CONTEXT: The polycystic ovary syndrome (PCOS) is the commonest endocrine abnormality in women of reproductive age. OBJECTIVE: To determine the rate of hospital admissions for women with PCOS in Western Australian population in comparison to women without PCOS. DESIGN: A population-based retrospective cohort study using data linkage in a statewide hospital morbidity database system. SETTING: All hospitals within Western Australia. PARTICIPANTS: A total of 2566 women with PCOS hospitalized from 1997-2011 and 25 660 randomly selected age-matched women without a PCOS diagnosis derived from the electoral roll. MAIN OUTCOME MEASURES: Hospitalizations by ICD-10-M diagnoses from 15 years were compared. RESULTS: Hospitalizations were followed until a median age of 35.8 years (interquartile range, 31.0-39.9). PCOS was associated with more nonobstetric and non-injury-related hospital admissions (median, 5 vs 2; P < .001), a diagnosis of adult-onset diabetes (12.5 vs 3.8%), obesity (16.0 vs 3.7%), hypertensive disorder (3.8 vs 0.7%), ischemic heart disease (0.8 vs 0.2%), cerebrovascular disease (0.6 vs 0.2%), arterial and venous disease (0.5 vs 0.2% and 10.4 vs 5.6%, respectively), asthma (10.6 vs 4.5%), stress/anxiety (14.0 vs 5.9%), depression (9.8 vs 4.3%), licit/illicit drug-related admissions (8.8 vs 4.5%), self-harm (7.2 vs 2.9%), land transport accidents (5.2 vs 3.8%), and mortality (0.7 vs 0.4%) (all P < .001). Women with PCOS had a higher rate of admissions for menorrhagia (14.1 vs 3.6%), treatment of infertility (40.9 vs 4.6%), and miscarriage (11.1 vs 6.1%) and were more likely to require in vitro fertilization (17.2 vs 2.0%). CONCLUSION: PCOS has profound medical implications for the health of women, and health care resources should be directed accordingly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prevalence of malignant cancer has been reported to be 2-fold greater or not different in those with PCOS.6,32”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [6]
In the citing paper
“The prevalence of endometrial cancer has been reported to be increased 3-5 fold in those with PCOS in the postmenopause years, and an increased risk for ovarian cancer has been reported in younger women with PCOS in the premenopause years.6,123, 124, 125”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [6]
In the citing paper
“Higher rates of endometriosis among women with PCOS (up to 70%) have been reported among women hospitalized for PCOS34 or with self-reported infertility and/or pelvic pain,21”
From Examining the co-occurrence of endometriosis and polycystic ovarian syndrome (2023) · cites this paper as [34]
In the citing paper
“Our data showed that mental health and psychiatric disorders had a 30% higher prevalence in those with PCOS, consistent with findings of previous population cohort studies.6,29,31,32,126,127”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [6]
In the citing paper
“The diagnosis of PCOS included the ICD-9 and ICD-10 codes, and these have been validated and used in previous epidemiologic studies.6,10,17,27,32,55, 56, 57”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [6]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976 · cited 6×
“experience a lower quality of life (2, 41, 42) and are prone”
BackgroundResultInfluentialLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919 · cited 2×
“tional Health and Medical Research Council (3), and in the United States by The Endocrine Society statement (4).”
BackgroundLegro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108 · cited 1×
“Our finding of a four times greater prevalence of type II diabetes among women with PCOS admitted to hospital is in agreement with the literature (2, 37).”
ResultHolman, C. D. J., Bass, A. J., Rouse, I. L., & Hobbs, M. S. T. (1999) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.1999.tb01297.x · Cited by 1,037 · cited 1×
“org/data-linkage/ data-collections) within the linked data from the WA Data-Linkage System that has been validated previously and used extensively for health research (26).”
MethodWild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Stepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747 · cited 2×
“This data linkage study cannot determine causality, only associations; however, insulin resistance is more prevalent in women with PCOS and may occur in up to 75% of lean women with PCOS (34), and it is believed that insulin resistance is integral to the underlying pathophysiology of the cardiometabolic perturbation i…”
Background
Cited by
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358
Cooney, L. G., Lee, I., Sammel, M. D., & Dokras, A. (2017) · Human Reproduction · doi:10.1093/humrep/dex044 · Cited by 631
Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
Wekker, V, van Dammen, L., Koning, A., Heida, K. Y., Painter, R. C., Limpens, J., Laven, J. S. E., Roeters van Lennep, J. E., Roseboom, T. J., & Hoek, A. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa029 · Cited by 425
Osibogun, O., Ogunmoroti, O., & Michos, E. D. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.08.010 · Cited by 423
Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences
Anagnostis, P., Tarlatzis, B. C., & Kauffman, R. P. (2018) · Metabolism · doi:10.1016/j.metabol.2017.09.016 · Cited by 416
Kakoly, N. S., Khomami, M. B., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., Ranasinha, S., Teede, H. J., & Moran, L. J. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy007 · Cited by 384
Current Guidelines for Diagnosing PCOS
Christ, J. P., & Cedars, M. I. (2023) · Diagnostics · doi:10.3390/diagnostics13061113 · Cited by 340
Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv025 · Cited by 334
Poly Cystic Ovarian Syndrome: An Updated Overview
El Hayek, S., Bitar, L., Hamdar, L. H., Mirza, F. G., & Daoud, G. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00124 · Cited by 323
“…such depression (Veltman-Verhulst et al., 2012), anxiety (Jedel et al., 2010; Veltman-Verhulst et al., 2012), recreational drugrelated incidents (Hart and Doherty, 2015), disordered eating, and psychosexual dysfunction (Deeks et al., 2010; Teede et al., 2011) in comparison to healthy female…”
BackgroundInfluentialAdolescent polycystic ovary syndrome according to the international evidence-based guideline
Peña, A. S., Witchel, S. F., Hoeger, K. M., Oberfield, S. E., Vogiatzi, M. G., Misso, M., Garad, R., Dabadghao, P., & Teede, H. (2020) · BMC Medicine · doi:10.1186/s12916-020-01516-x · Cited by 301
Female infertility, infertility-associated diagnoses, and comorbidities: a review
Hanson, B., Johnstone, E., Dorais, J., Silver, B., Peterson, C. M., & Hotaling, J. (2017) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-016-0836-8 · Cited by 297
Oocyte competence in women with polycystic ovary syndrome
Palomba, S., Daolio, J., & La Sala, G. B. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.11.008 · Cited by 294
Dokras, A., Stener-Victorin, E., Yildiz, B. O., Li, R., Ottey, S., Shah, D., Epperson, N., & Teede, H. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.01.038 · Cited by 285
Estrogen-Receptor Expression and Function in Female Reproductive Disease
Tang, Z.-R., Zhang, R., Lian, Z.-X., Deng, S.-L., & Yu, K. (2019) · Cells · doi:10.3390/cells8101123 · Cited by 274
“PCOS women are at least three times more likely to develop endometrial cancer (EC) [87,88].”
Beyond fertility: polycystic ovary syndrome and long-term health
Cooney, L. G., & Dokras, A. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.08.021 · Cited by 270
Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv063 · Cited by 255
“Women with PCOS had twice as many hospital admissions as women without the condition over the 15-year follow-up (Hart and Doherty, 2015).”
BackgroundPhysiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics
Hart, R. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00023.2015 · Cited by 228
Self-citationCesta, C. E., Månsson, M., Palm, C., Lichtenstein, P., Iliadou, A. N., & Landén, M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.005 · Cited by 217
“…and eating disorders corroborates earlier findings from small clinical studies (Mansson et al., 2008; Scaruffi et al., 2014) and two recent population-based studies,(Hart and Doherty, 2014; Hung et al., 2014) whereas few to no previous studies have linked PCOS with more rare psychiatric disorders.”
BackgroundResultInfluentialBahri Khomami, M., Joham, A. E., Boyle, J. A., Piltonen, T., Silagy, M., Arora, C., Misso, M. L., Teede, H. J., & Moran, L. J. (2019) · Obesity Reviews · doi:10.1111/obr.12829 · Cited by 211
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
Glintborg, D., Rubin, K. H., Nybo, M., Abrahamsen, B., & Andersen, M. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0680-5 · Cited by 200
“We could confirm results from recent studies where the OR for CVD was increased in women with PCOS [5–8, 23, 24].”
ResultThe Diagnosis of Polycystic Ovary Syndrome in Adolescents
Rosenfield, R. L. (2015) · Pediatrics · doi:10.1542/peds.2015-1430 · Cited by 195
Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease
Guan, C., Zahid, S., Minhas, A. S., Ouyang, P., Vaught, A., Baker, V. L., & Michos, E. D. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.009 · Cited by 188
Salari, N., Nankali, A., Ghanbari, A., Jafarpour, S., Ghasemi, H., Dokaneheifard, S., & Mohammadi, M. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07607-x · Cited by 181
“Individuals with PCOS are at risk for several ailments and diseases including obesity, metabolic syndrome, insulin resistance, type 2 diabetes, infertility, cancer, cardiovascular disease, and mental disorders[7, 8], affecting different aspects of their quality of life [9].”
Mills, G., Badeghiesh, A., Suarthana, E., Baghlaf, H., & Dahan, M. H. (2020) · Human Reproduction · doi:10.1093/humrep/deaa099 · Cited by 181
Ollila, M.-M. E., Piltonen, T., Puukka, K., Ruokonen, A., Järvelin, M.-R., Tapanainen, J. S., Franks, S., & Morin-Papunen, L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3543 · Cited by 182
Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment
Cooney, L. G., & Dokras, A. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0834-2 · Cited by 165
The prevalence of polycystic ovary syndrome in adolescents: A systematic review and meta-analysis
Saei Ghare Naz, M., Ramezani Tehrani, F., Alavi Majd, H., Ahmadi, F., Ozgoli, G., Rashidi Fakari, F., & Ghasemi, V. (2019) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v17i8.4818 · Cited by 151
“This multi-factorial syndrome initially appears in puberty (5), and individuals with this disease may be exposed to the risk of several diseases, including obesity, metabolic syndrome, insulin resistance, type-II diabetes, infertility, cancer, cardiovascular disease, and mental disorders (6, 7), affecting several dime…”
BackgroundImplications of Polycystic Ovary Syndrome for Pregnancy and for the Health of Offspring
Doherty, D. A., Newnham, J. P., Bower, C., & Hart, R. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000852 · Cited by 146
“We have compared the health outcomes between women hospitalized with PCOS and women who had hospitalizations without a PCOS diagnosis.(18) We aimed to determine significant health associations for women with PCOS reported by others.”
ResultSelf-citationBerni, T. R., Morgan, C. L., & Rees, D. A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab392 · Cited by 146
“9 reported an increased risk of hospitalization for ischemic heart disease and cerebrovascular disease in their study of 2,566 women with PCOS and 25,660 age-matched women without a diagnosis of PCOS in Western Australia (15).”
BackgroundInfluentialBarrett, E. S., Hoeger, K. M., Sathyanarayana, S., Abbott, D. H., Redmon, J. B., Nguyen, R. H. N., & Swan, S. H. (2018) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174417001118 · Cited by 145
Heavy Menstrual Bleeding in Adolescents
Haamid, F. W., Sass, A. E., & Dietrich, J. E. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.01.002 · Cited by 166
Is fertility reduced in ovulatory women with polycystic ovary syndrome? An opinion paper
Palomba, S. (2021) · Human Reproduction · doi:10.1093/humrep/deab181 · Cited by 161
Amiri, M., Ramezani Tehrani, F., Behboudi-Gandevani, S., Bidhendi-Yarandi, R., & Carmina, E. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00576-1 · Cited by 136
Fernandez, R., Moore, V., Van Ryswyk, E., Varcoe, T., Rodgers, R., March, W., Moran, L., Avery, J., McEvoy, D., & Davies, M. (2018) · Nature and Science of Sleep · doi:10.2147/nss.s127475 · Cited by 137
“154 In a retrospective cohort study, women with PCOS (n = 319) identified through hospital records were compared with age-matched women (n = 1060) identified through general practice records.”
ResultPolycystic ovary syndrome: Endometrial markers
Piltonen, T. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.03.008 · Cited by 149
Criteria, phenotypes and prevalence of polycystic ovary syndrome
Belenkaia, L. V., Лазарева, Л. М., Walker, W., Lizneva, D., & Сутурина, Л. В. (2019) · Minerva Obstetrics and Gynecology · doi:10.23736/s0026-4784.19.04404-6 · Cited by 145
Insulin-Like Growth Factor-I is a Marker for the Nutritional State.
Hawkes, C. P., & Grimberg, A. (2015) · PubMed · Cited by 185
Lipid metabolism and endometrial receptivity
Yang, T., Zhao, J., Liu, F., & Li, Y. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac026 · Cited by 151
Wiwatpanit, T., Murphy, A. R., Lu, Z., Urbanek, M., Burdette, J. E., Woodruff, T. K., & Kim, J. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz100 · Cited by 136
Karjula, S., Morin-Papunen, L., Auvinen, J., Ruokonen, A., Puukka, K., Franks, S., Järvelin, M.-R., Tapanainen, J. S., Jokelainen, J., Miettunen, J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3863 · Cited by 122
“The questionnaire included questions on weight and height and questions screening for PCOS symptoms: (1) Is your menstrual cycle longer than 35daysmore than twice a year (OA)? (2) Do you have excessive body hair (H)? Of all women, 10.”
BackgroundSPOSDS: A smart Polycystic Ovary Syndrome diagnostic system using machine learning
Tiwari, S., Kane, L., Koundal, D., Jain, A., Alhudhaif, A., Polat, K., Zaguia, A., Alenezi, F. S., & Althubiti, S. A. (2022) · Expert Systems with Applications · doi:10.1016/j.eswa.2022.117592 · Cited by 148
Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome
Deng, H., Chen, Y., Xing, J., Zhang, N., & Xu, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1470283 · Cited by 170
Pinola, P., Puukka, K., Piltonen, T. T., Puurunen, J., Vanky, E., Sundström-Poromaa, I., Stener-Victorin, E., Lindén Hirschberg, A., Ravn, P., Skovsager Andersen, M., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.12.017 · Cited by 113
Polycystic Ovary Syndrome Is Associated With Adverse Mental Health and Neurodevelopmental Outcomes
Berni, T. R., Morgan, C. L., Berni, E. R., & Rees, D. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02667 · Cited by 111
“pression and anxiety with time have been found in Taiwanese (17) and Australian (33) patients with PCOS.”
BackgroundTay, C. T., Mousa, A., Vyas, A., Pattuwage, L., Tehrani, F. R., & Teede, H. J. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.033572 · Cited by 156
“24,26,28,29,31,40,45 Three studies used laparoscopy for PCOS diagnosis, 32,33,44 whereas 1 used self-report 41 and another used Androgen Excess and PCOS Society criteria.”
Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome
Brown, J., & Farquhar, C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002249.pub5 · Cited by 99
Polycystic ovary syndrome: Understanding the role of the brain
Moore, A. M., & Campbell, R. E. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.05.002 · Cited by 113
“likely to be admitted to the hospital for depression, anxiety, self-harm and recreational drug use than women without PCOS (Hart and Doherty, 2015).”
BackgroundZhang, J., Xu, J.-H., Qu, Q.-Q., & Zhong, G.-Q. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.552421 · Cited by 96
Pediatric obesity: Current concepts
Greydanus, D. E., Agana, M. G., Kamboj, M. K., Shebrain, S., Soares, N. S., Eke, R., & Patel, D. R. (2018) · Disease-a-Month · doi:10.1016/j.disamonth.2017.12.001 · Cited by 129
Tyrmi, J. S., Arffman, R. K., Pujol‐Gualdo, N., Kurra, V., Morin-Papunen, L. C., Sliz, E., FinnGen, Piltonen, T., Laisk, T., Kettunen, J., et al. (2021) · Human Reproduction · doi:10.1093/humrep/deab250 · Cited by 103
Nilsson, E., Benrick, A., Kokosar, M., Krook, A., Lindgren, E., Källman, T., Martis, M. M., Højlund, K., Ling, C., & Stener-Victorin, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00935 · Cited by 93
“The overall presence of thyroid diseases, ast hma and type 1 diabetes is increased in PCOS patients versus controls (42,43).”
BackgroundBiomarker Profiles in Women with PCOS and PCOS Offspring; A Pilot Study
Daan, N. M. P., Koster, M. P. H., de Wilde, M. A., Dalmeijer, G. W., Evelein, A. M. V., Fauser, B. C. J. M., & de Jager, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165033 · Cited by 96
The Health Consequences of Obesity in Young Adulthood
Cheng, H. L., Medlow, S., & Steinbeck, K. S. (2016) · Current Obesity Reports · doi:10.1007/s13679-016-0190-2 · Cited by 123
“A recent data linkage study from Australia showed that PCOS was associated with more non-obstetric and noninjury-related hospital admissions, as well as higher hospitalisation rates for menorrhagia [59].”
Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis
Al Khalifah, R. A., Florez, I. D., Dennis, B., Thabane, L., & Bassilious, E. (2016) · PEDIATRICS · doi:10.1542/peds.2015-4089 · Cited by 91
Ramezani Tehrani, F., Amiri, M., Behboudi-Gandevani, S., Bidhendi-Yarandi, R., & Carmina, E. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1650337 · Cited by 91
“Four studies diagnosed PCOS using the Rotterdam criteria [30,35,39,41], three the NIH [28,34,38], one the AES [33], five the ICD [29,31,32,36,37], and three studies used laparoscopic criteria [18,19,40] (Table 1).”
BackgroundMethodMerz, C. N. B., Shaw, L. J., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2016) · Journal of Women's Health · doi:10.1089/jwh.2015.5441 · Cited by 87
Daan, N. M. P., Jaspers, L., Koster, M. P. H., Broekmans, F. J. M., de Rijke, Y. B., Franco, O. H., Laven, J. S. E., Kavousi, M., & Fauser, B. C. J. M. (2015) · Human Reproduction · doi:10.1093/humrep/dev195 · Cited by 76
Bahri Khomami, M., Joham, A. E., Boyle, J. A., Piltonen, T., Arora, C., Silagy, M., Misso, M. L., Teede, H. J., & Moran, L. J. (2019) · Obesity Reviews · doi:10.1111/obr.12832 · Cited by 75
Emanuel, R. H. K., Roberts, J., Docherty, P. D., Lunt, H., Campbell, R. E., & Möller, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1017468 · Cited by 101
“cardiovascular disease (6), insulin resistance (7), obesity (8), infertility (6), pregnancy complications (9, 10), sleep disturbances (11), hypothyroidism (12), decreased mental health (13), and non-alcoholic fatty liver disease (NAFLD) (14).”
BackgroundYu, O., Christ, J. P., Schulze‐Rath, R., Covey, J., Kelley, A., Grafton, J. R., Cronkite, D., Holden, E., Hilpert, J., Sacher, F., et al. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.04.010 · Cited by 101
Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies
Kamboj, M. K., & Bonny, A. E. (2017) · Translational Pediatrics · doi:10.21037/tp.2017.09.11 · Cited by 100
“It is associated with significant morbidity including impaired reproductive health, psychosocial dysfunction, metabolic syndrome, cardiovascular disease, and increased cancer r isk (2,3).”
BackgroundPsychiatric disorders in women with polycystic ovary syndrome
Rodriguez-Paris, D., Remlinger-Molenda, A., Kurzawa, R., Głowińska, A., Spaczyński, R., Rybakowski, F., Pawelczyk, L. A., & Banaszewska, B. (2019) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/93105 · Cited by 93
Gleason, J. L., Shenassa, E. D., & Thoma, M. E. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.10.009 · Cited by 80
Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life?
Gunning, M. N., & Fauser, B. C. J. M. (2017) · Climacteric · doi:10.1080/13697137.2017.1316256 · Cited by 71
“In contrast to the previously three mentioned smaller studies, Hart and Doherty showed that ischemic heart disease (hazard ratio (HR) 2.89; 95% CI 1.68 – 4.97) and all-cause mortality (HR 1.89; 95% CI 1.12 – 3.17) were higher in women with PCOS 37 (Table 4).”
InfluentialYoung women's psychological distress after a diagnosis of polycystic ovary syndrome or endometriosis
Rowlands, I. J., Teede, H., Lucke, J., Dobson, A. J., & Mishra, G. D. (2016) · Human Reproduction · doi:10.1093/humrep/dew174 · Cited by 70
Skarra, D. V., Hernandez, A. M., Rivera, A. J., Anvar, A. R., & Thackray, V. G. (2017) · Endocrinology · doi:10.1210/en.2016-1898 · Cited by 83
Arentz, S., Smith, C. A., Abbott, J., & Bensoussan, A. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-2011-x · Cited by 66
“PCOS has broad health implications including adverse metabolic (obesity, type two diabetes, cardio vascular disease), reproductive (infertility, miscarriage, pregnancy and neonatal complications) [3, 4], and psychological (anxiety, depression and stress) [5, 6] risks.”
BackgroundWilliams, S., Sheffield, D., & Knibb, R. C. (2015) · Health Psychology Open · doi:10.1177/2055102915603051 · Cited by 65
Zhou, Y., Wang, X., Jiang, Y., Ma, H., Chen, L., Lai, C., Peng, C., He, C., & Sun, C. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1347779 · Cited by 64
Long‐term health outcomes in young women with polycystic ovary syndrome: A narrative review
Allen, L. A., Shrikrishnapalasuriyar, N., & Rees, D. A. (2022) · Clinical Endocrinology · doi:10.1111/cen.14609 · Cited by 62
Graff, S. K., Mario, F. M., Ziegelmann, P., & Spritzer, P. M. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12787 · Cited by 63
MANAGEMENT OF ENDOCRINE DISEASE: Morbidity in polycystic ovary syndrome
Glintborg, D., & Andersen, M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0373 · Cited by 63
Body image, personality profiles and alexithymia in patients with polycystic ovary syndrome (PCOS)
Scaruffi, E., Franzoi, I. G., Civilotti, C., Guglielmucci, F., La Marca, L., Tomelini, M., Veglia, F., & Granieri, A. (2019) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2018.1530210 · Cited by 62
“132 Moreover, women with PCOS are approximately twice as likely to be hospitalized for 133 stress, anxiety, depression, illicit drug use, and self-harm behaviors [37].”
BackgroundTorres, P. J., Skarra, D. V., Ho, B., Sau, L., Anvar, A. R., Kelley, S. T., & Thackray, V. G. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1425-7 · Cited by 70
Moran, L. J., Brown, W. J., McNaughton, S. A., Joham, A. E., & Teede, H. J. (2017) · Human Reproduction · doi:10.1093/humrep/dew348 · Cited by 59
“It is associated with adverse reproductive, metabolic and psychological features (Moran et al., 2010a,b; Barry et al., 2011; Hart and Doherty, 2015).”
BackgroundWeight management interventions in women with and without PCOS: a systematic review
Kataoka, J., Tassone, E., Misso, M., Joham, A., Stener-Victorin, E., Teede, H., & Moran, L. (2017) · Nutrients · doi:10.3390/nu9090996 · Cited by 58
Daan, N. M. P., Koster, M. P. H., Steegers‐Theunissen, R. P. M., Eijkemans, M. J. C., & Fauser, B. C. J. M. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.09.042 · Cited by 61
“005 Vaginal assisted 15 (25) 7 (9) Planned cesarean delivery 3 (5) 10 (12) Unplanned cesarean delivery 5 (8) 13 (16) Maternal pregnancy complications Gestational diabetes 16 (26) 10 (12) .”
BackgroundPregnancy-related outcomes for women with polycystic ovary syndrome
McDonnell, R., & Hart, R. J. (2017) · Women s Health · doi:10.1177/1745505717731971 · Cited by 71
Self-citationSydora, B. C., Wilke, M. S., McPherson, M., Chambers, S., Ghosh, M., & Vine, D. F. (2023) · BMC Women's Health · doi:10.1186/s12905-023-02732-2 · Cited by 60
“PCOS impacts overall health and quality of life across the lifespan from childhood to post-menopause [5–9].”
BackgroundYang, C., Xi, M., Liu, H., Bai, H., Jiang, C., Liu, Q., & Fan, P. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00764-3 · Cited by 57
Ayonrinde, O. T., Adams, L. A., Doherty, D. A., Mori, T. A., Beilin, L. J., Oddy, W. H., Hickey, M., Sloboda, D. M., Olynyk, J. K., & Hart, R. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13241 · Cited by 55
Self-citationLewandowski, K. C., Skowrońska‐Jóźwiak, E., Łukasiak, K., Gałuszko, K., Dukowicz, A., Cedro, M., & Lewiñski, A. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.82672 · Cited by 70
“It is well recognized that a significant proportion of women with PCOS have a propensity towards obesity, dyslipidaemia, insulin resistance, as well as abnormal glucose homeostasis (impaired fasting glucose, impaired glucose tolerance, type 2 diabetes) [5, 6].”
Raja, M. A., Maldonado, M., Chen, J., Zhong, Y., & Gu, J. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s302161 · Cited by 72
Joham, A. E., Kakoly, N. S., Teede, H. J., & Earnest, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab134 · Cited by 59
Chiofalo, F., Ciuoli, C., Formichi, C., Selmi, F., Forleo, R., Neri, O., Vuolo, G., Paffetti, P., & Pacini, F. (2017) · Obesity Surgery · doi:10.1007/s11695-016-2528-y · Cited by 88
Patel, V., Menezes, H., Menezes, C., Bouwer, S., Bostick-Smith, C. A., & Speelman, D. L. (2020) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2020.050 · Cited by 80
Vine, D., Ghosh, M., Wang, T., & Bakal, J. (2024) · CJC Open · doi:10.1016/j.cjco.2023.12.010 · Cited by 53
“6,32 123-125 In our cohort, we have shown that all malignancy was increased by 30% in those with PCOS, suggesting that increased awareness and screening may be warranted.”
BackgroundResultInfluentialSaleem, F., & Rizvi, S. W. (2017) · Cureus · doi:10.7759/cureus.1844 · Cited by 52
“To understand the scale of the problem and the importance of research and resource allocation for women with PCOS, a study was conducted in Australia [3].”
Behboodi Moghadam, Z., Fereidooni, B., Saffari, M., & Montazeri, A. (2018) · BMC Women's Health · doi:10.1186/s12905-018-0658-1 · Cited by 50
Krug, I., Giles, S., & Paganini, C. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s168944 · Cited by 50
Karjula, S., Morin-Papunen, L., Franks, S., Auvinen, J., Järvelin, M.-R., Tapanainen, J. S., Jokelainen, J., Miettunen, J., & Piltonen, T. T. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz256 · Cited by 49
Postpartum complications increased in women with polycystic ovary syndrome
Alur-Gupta, S., Boland, M. R., Barnhart, K. T., Sammel, M. D., & Dokras, A. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.08.048 · Cited by 53
Pregnancy outcomes in women with polycystic ovarian syndrome
D’Alterio, M. N., Sigilli, M., Succu, A. G., GHISU, V., Laganà, A. S., Sorrentino, F., Nappi, L., Tinelli, R., & Angioni, S. L. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04758-4 · Cited by 53
Papalou, O., & Diamanti-Kandarakis, E. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1266250 · Cited by 47
Kałużna, M., Człapka-Matyasik, M., Wachowiak-Ochmańska, K., Moczko, J., Kaczmarek, J., Janicki, A., Piątek, K., Ruchała, M., & Ziemnicka, K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9093024 · Cited by 47
Prevalence and Etiology of Eating Disorders in Polycystic Ovary Syndrome: A Scoping Review
Lalonde-Bester, S., Malik, M., Masoumi, R., Ng, K., Sidhu, S., Ghosh, M., & Vine, D. F. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2024.100193 · Cited by 63
“Polycystic ovary syndrome (PCOS) is the most common endocrine-metabolic disorder affecting 6% – 20% of females and impacting health and quality of life across the lifespan [1 – 6].”
BackgroundCardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study
Behboudi-Gandevani, S., Ramezani Tehrani, F., Hosseinpanah, F., Khalili, D., Cheraghi, L., Kazemijaliseh, H., & Azizi, F. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.08.046 · Cited by 46
Polycystic ovary syndrome and aging: Health implications after menopause
Helvacı, N., & Yıldız, B. O. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.05.013 · Cited by 55
Gariani, K., Hugon‐Rodin, J., Philippé, J., Righini, M., & Blondon, M. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.11.019 · Cited by 47
Metadata
- Authors
- Hart, R., & Doherty, D. A.
- Affiliations
- The University of Western Australia (AU)
- Corresponding author
- Hart, Roger
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-03
- Volume
- 100
- Issue
- 3
- Pages
- 911-919
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2098409670
- Cited by
- 391
- References
- 51
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 39 · 2023: 35 · 2022: 45 · 2021: 41 · 2020: 43 · 2019: 38 · 2018: 34 · 2017: 32 · 2016: 33 · 2015: 12
- FWCI
- 31.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, long-term health effects, hospitalization, type 2 diabetes, obesity, depression, anxiety, infertility, miscarriage, in vitro fertilization, menorrhagia, mortality, Western Australia, healthcare resource allocation, data linkage, women's health, vascular disease
- MeSH terms
- Adolescent, Adult, Australia, Data Collection, Female, Hospitalization, Humans, Middle Aged, Polycystic Ovary Syndrome, Pregnancy, Time Factors, Comorbidity, Case-Control Studies, Young Adult, Reproductive Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.